Good morning, everyone, and how are you today? Sunny skies are lighting up the Pharmalot corporate campus, where we are hustling to take those short people to their assorted school houses. As usual, this places us behind schedule. Nonetheless, we will persevere. To cope, of course, we are brewing that mandatory cup of stimulation - Rain Forest Nut is on the menu - and invite you to join us. There is much to do, so let the games begin. Hope your day goes well and do stay in touch...
Roche Settles Lawsuit Over Raptiva Infections (Bloomberg News)
Watson Buys Strides' Australia Unit For $396 Million (Reuters)
Magic Mushrooms Point To New Depression Drugs (Reuters)
Vertex Digs In For Fight Over Hepatitis C Market (Xconomy)
US Consumers Want Insurers To Cover Experimental Drugs (Reuters)
Drug Seen To Curtail Cancer Left In Prostate (New York Times)
Takeda Wins FDA Approval For Injectable Velcade (Bloomberg News)
FDA Extends Review Of Alexza Bipolar Drug (MarketWatch)
Ireland Can Cut Branded Rx Prices By 25 Percent: Study (Pharma Times)
Medicines Company And APP Settle Patent Lawsuit (Bloomberg News)
EDITOR'S NOTE: Please check this post for updates throughout the morning
sunrise pic thx to benimoto on flickr